QUADEX PHARMACEUTICALS LLC has a total of 30 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and medical technology are DEPOMED INC, NOVADEL PHARMA INC and DUGGER III HARRY A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Brazil | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | Israel | 2 | |
#8 | Mexico | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | China | 1 | |
#11 | New Zealand | 1 | |
#12 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Johnson B Ron | 25 |
#2 | Mccarthy James P | 12 |
#3 | Johnson Ron B | 1 |
#4 | James P Mccarthy | 1 |
#5 | Ron B Johnson | 1 |
#6 | B Ron Johnson | 1 |
Publication | Filing date | Title |
---|---|---|
US2015374704A1 | Combined systemic and topical treatment of disordered and/or prodromal stage tissue | |
US2014275248A1 | Treatment of molluscum contagiosum | |
US2014274939A1 | Combined systemic and topical treatment of disordered tissues | |
EP1404174A2 | Anti-infective compositions for treating disordered tissue such as cold sores |